Rchr
J-GLOBAL ID：200901081913306897   Update date: Nov. 30, 2024

Hijiya Naoki

ヒジヤ ナオキ | Hijiya Naoki
Affiliation and department：
Oita University Faculty of Medicine, Department of Molecular Pathology

About Oita University Faculty of Medicine, Department of Molecular Pathology


Job title： Assistant Professor,Assistant Professor
Homepage URL  (1)： http://www.med.oita-u.ac.jp/byori2/index.htm
Research field  (2)： Experimental pathology ,  Human pathology
Research keywords  (4)： 人体病理学 ,  実験病理学 ,  Surgical Pathology ,  Experimental Pathology
Research theme for competitive and other funds  (34)：
  • 2024 - 2028 Development of new diagnostic and therapeutic strategies targeting the molecular basis contributing to invasion of pancreatic cancer
  • 2024 - 2027 Development of a new therapeutic strategy targeting Clusterin, a molecule associated with treatment resistance in pancreatic cancer
  • 2023 - 2026 大腸癌の新規がん遺伝子VSNL-1の機能解明と臨床応用
  • 2023 - 2026 Elucidation of stromal changes in pancreatic cancer caused by neoadjuvant chemotherapy and establishment of new treatment
  • 2023 - 2026 膵癌の浸潤に関与する新規がん抑制遺伝子PLEKHA2の機能解明と治療応用
Show all
Papers (94)：
  • 平下 有香, 塚本 善之, 泥谷 直樹, 小坂 聡太郎, 高橋 晴彦, 福田 健介, 岡本 和久, 小川 竜, 水上 一弘, 兒玉 雅明, et al. 胆汁酸はERKシグナル伝達経路を介し化生変化を誘導する. 日本胃癌学会総会記事. 2024. 96回. 377-377
  • Yu Wang, Shunsuke Shimosaki, Emi Ikebe, Hidekatsu Iha, Jun-ichi Yamamoto, Nichole Fife, Tomonaga Ichikawa, Mitsuo Hori, Masao Ogata, Yoshiyuki Tsukamoto, et al. IMiD/CELMoD-induced growth suppression of adult T-cell leukemia/lymphoma cells via cereblon through downregulation of target proteins and their downstream effectors. Frontiers in Oncology. 2024. 13
  • Takafumi Fuchino, Shusaku Kurogi, Yoshiyuki Tsukamoto (corresponding author, Tomotaka Shibata, Shoichi Fumoto, Hajime Fujishima, Keisuke Kinoshita, Yuka Hirashita, Masahide Fukuda, Chisato Nakada, et al. Characterization of residual cancer by comparison of a pair of organoids established from a patient with esophageal squamous cell carcinoma before and after neoadjuvant chemotherapy. Human Cell. 2024
  • Takayuki Aiba, Naoki Hijiya, Tomonori Akagi, Yoshiyuki Tsukamoto, Yuka Hirashita, Keisuke Kinoshita, Tomohisa Uchida, Chisato Nakada, Shusaku Kurogi, Yoshitake Ueda, et al. Overexpression of VSNL1 enhances cell proliferation in colorectal carcinogenesis. Pathobiology : journal of immunopathology, molecular and cellular biology. 2023
  • Yoshiyuki Tsukamoto, Shusaku Kurogi, Hajime Fujishima, Tomotaka Shibata, Shoichi Fumoto, Kohei Nishiki, Kosuke Suzuki, Tsuyoshi Etoh, Norio Shiraishi, Takafumi Fuchino, et al. Association of immune-related expression profile with sensitivity to chemotherapy in esophageal squamous cell carcinoma. Cancer science. 2023
ｍore...
MISC (34)：
  • 中田知里, 白石裕士, 池内真代, 池内真代, 清水誠之, 浜松典子, 塚本善之, 泥谷直樹, 安藤忠助, 花田俊勝, et al. 腎淡明細胞癌で異常発現するmiR-210の生物学的機能の解析. 泌尿器科分子・細胞研究会プログラム・抄録集. 2024. 33rd
  • 泥谷直樹, 塚本善之, 黒木秀作, 中田知里, 守山正胤. Clusterin is involved in the refractory response of pancreatic cancer cells to a MAP kinase inhibitor. 日本癌学会学術総会抄録集(Web). 2023. 82nd
  • 黒木秀作, 泥谷直樹, 塚本善之, 中田知里, 猪股雅史, 小林隆志, 守山正胤. ANXA8 is involved in the resistance to MAPK inhibitor in pancreatic cancer. 日本癌学会学術総会抄録集(Web). 2023. 82nd
  • 塚本善之, 渕野貴文, 黒木秀作, 柴田智隆, 藤島紀, 板井勇介, 麓祥一, 猪股雅史, 村上和成, 泥谷直樹. 術前化学療法の効果が低かった食道癌1例の化学療法前・後から樹立した癌オルガノイドの解析. 日本ヒト細胞学会学術集会. 2023. 41st
  • Shusaku Kurogi, Naoki Hijiya, Yoshiyuki Tsukamoto, Chisato Nakada, Masafumi Inomata, Takashi Kobayashi, Masatsugu Moriyama. Downregulation of ZNF395 enhances cell proliferation in pancreatic ductal adenocarcinoma through inactivation of JNK. CANCER SCIENCE. 2022. 113. 567-567
ｍore...
Books (1)：
  • Role of CD14 in infection : studies in CD14-deficient mice Endotoxin and sepsis molecular mechanisms of pathagenesis, host resistance and therapy
    Wiley-Liss 1998
Professional career (1)：
  • (BLANK)
Association Membership(s) (3)：
日本癌学会 ,  日本病理学会 ,  日本分子生物学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM